Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04946370 |
| Title | Maximizing Responses to Anti-PD1 Immunotherapy With PSMA-targeted Alpha Therapy in mCRPC |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Weill Medical College of Cornell University |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| New York Presbyterian/Brooklyn Methodist Hospital | Brooklyn | New York | 11215 | United States | Details | |
| New York Presbyterian/Weill Cornell Medical Center | New York | New York | 10021 | United States | Details | |
| Columbia University Irving Cancer Center | New York | New York | 10032 | United States | Details |